New Anteo poster - Clue on Top 10 IVD?, page-3

Good stuff Twin, you can probably tell my frustration from recent posts, the quality and broad applicability of the tech remains amazing.

These bigger fish seem to be able to ignore with impunity for now, it's a real pity that acquisition last year didn't come off, having our own products hitting market in volume is one of the only ways I see change being forced, the status quo just seems so entrenched with no apparent appetite for change until it's forced by cheaper competition. (although we were 'priced out' of that deal one wonders if the opportunity cost in delays since indicate that we should have bid up). You can guarantee that if Roche or a similar company had come up with M&G in house it'd be used across thousands of tests by now. Just need one deal to drop... the upswing at that point should be impressive given how much the free float continues to shrink...

Time to sit on ones hands (perhaps including my HC posts).